UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.47B |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$2.93B |
| 3 |
Vanguard Russell 1000 Value ETF
VONV
|
+$2.75B |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.69B |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$2.33B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.44B |
| 2 |
Micron Technology
MU
|
+$919M |
| 3 |
CYBR
CyberArk
CYBR
|
+$851M |
| 4 |
Honeywell
HON
|
+$606M |
| 5 |
Merck
MRK
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.16% |
| 2 | Technology | 16.96% |
| 3 | Financials | 8.4% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6051
First Capital
FCAP
$210M
| $497K | ﹤0.01% |
10,007
-8,643
| -46% | -$446K |
2024 Q3
6 quarters
|
|
6052
LENSAR
LNSR
$82.9M
| $496K | ﹤0.01% |
83,272
+74,885
| +893% | +$813K |
2020 Q4
21 quarters
|
|
6053
CALL
Bath & Body Works
BBWI
$3.24B
| $495K | ﹤0.01% |
26,500
-15,500
| -37% | -$335K |
2025 Q4
1 quarter
|
|
6054
ProQR Therapeutics
PRQR
$231M
| $495K | ﹤0.01% |
305,264
-492,400
| -62% | -$807K |
2022 Q3
14 quarters
|
|
6055
LeaderShares Dynamic Yield ETF
DYLD
$36.3M
| $495K | ﹤0.01% |
22,067
-12,466
| -36% | -$281K |
2023 Q3
10 quarters
|
|
6056
Westrock Coffee
WEST
$795M
| $493K | ﹤0.01% |
116,025
+59,336
| +105% | +$265K |
2022 Q3
14 quarters
|
|
6057
Caribou Biosciences
CRBU
$131M
| $492K | ﹤0.01% |
259,169
-378,576
| -59% | -$650K |
2021 Q3
18 quarters
|
|
6058
Organogenesis Holdings
ORGO
$171M
| $492K | ﹤0.01% |
207,528
+74,920
| +56% | +$260K |
2019 Q2
27 quarters
|
|
|
MREO
6059
Mereo BioPharma
MREO
$60.7M
| $492K | ﹤0.01% |
1,490,128
-68,803
| -4% | -$29.5K |
2024 Q4
5 quarters
|
|
|
OSTX
6060
OS Therapies Inc
OSTX
$75.8M
| $492K | ﹤0.01% |
348,678
+330,522
| +1,820% | +$469K |
2025 Q2
3 quarters
|
|
|
PNNT
6061
Pennant Park Investment Corp
PNNT
$212M
| $490K | ﹤0.01% |
109,198
+67,383
| +161% | +$358K |
2014 Q4
45 quarters
|
|
6062
8x8 Inc
EGHT
$329M
| $489K | ﹤0.01% |
294,552
+158,889
| +117% | +$325K |
2014 Q4
45 quarters
|
|
6063
CALL
Tronox
TROX
$628M
| $489K | ﹤0.01% |
+50,000
| New | +$347K |
2026 Q1
0 quarters
|
|
6064
CALL
APA Corp
APA
$15.3B
| $488K | ﹤0.01% |
11,500
| – | – |
2025 Q3
2 quarters
|
|
|
6065
PUT
APA Corp
APA
$15.3B
| $488K | ﹤0.01% |
11,500
| – | – |
2025 Q1
4 quarters
|
|
6066
PUT
Sabre
SABR
$795M
| $487K | ﹤0.01% |
336,000
| – | – |
2025 Q2
3 quarters
|
|
|
VRE
6067
DELISTED
Veris Residential
VRE
| $485K | ﹤0.01% |
25,706
-244,234
| -90% | -$4.14M |
2014 Q4
45 quarters
|
|
6068
Atossa Therapeutics
ATOS
$23.4M
| $484K | ﹤0.01% |
92,034
+66,033
| +254% | +$418K |
2023 Q3
10 quarters
|
|
6069
Mid Penn Bancorp
MPB
$922M
| $482K | ﹤0.01% |
14,992
-105,216
| -88% | -$3.41M |
2018 Q2
31 quarters
|
|
|
PMM
6070
Franklin Managed Municipal Income Trust
PMM
$242M
| $481K | ﹤0.01% |
78,196
+5,116
| +7% | +$32.1K |
2014 Q4
45 quarters
|
|
6071
iShares Paris-Aligned Climate Optimized MSCI USA ETF
PABU
$2.49B
| $481K | ﹤0.01% |
7,253
+902
| +14% | +$63K |
2023 Q4
9 quarters
|
|
6072
CALL
NovoCure
NVCR
$1.74B
| $480K | ﹤0.01% |
+44,000
| New | +$550K |
2026 Q1
0 quarters
|
|
|
EFR
6073
Eaton Vance Senior Floating-Rate Fund
EFR
$306M
| $477K | ﹤0.01% |
45,221
-1,475
| -3% | -$16K |
2014 Q4
45 quarters
|
|
6074
State Street SPDR S&P North American Natural Resources ETF
NANR
$806M
| $477K | ﹤0.01% |
5,673
+1,497
| +36% | +$119K |
2017 Q4
33 quarters
|
|
6075
QuickLogic
QUIK
$217M
| $477K | ﹤0.01% |
50,800
+20,287
| +66% | +$166K |
2020 Q2
23 quarters
|
|
Similar funds
UBS Group's Q1 2026 Portfolio in Review
As of Q1 2026, UBS Group held 11,786 positions worth $666B, up 8% from $617B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $74.2B of net new capital in Q1 2026, opening 1,344 new positions and adding to 4,798 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UBS Group, an estimated $1.44B trimmed.
- UBS Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $4.47B increase.
- UBS Group's biggest Q1 2026 reduction was UBS Group, cutting an estimated $1.44B.
- UBS Group fully exited CyberArk in Q1 2026, selling an estimated $851M.
- UBS Group's ten largest holdings make up 13% of its $666B portfolio in Q1 2026.
- UBS Group opened 1,344 new positions and closed 1,383 in Q1 2026.
- UBS Group's portfolio value rose 8% quarter-over-quarter to $666B.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.